300110.SZ · 华仁药业
China A-shares · RS rating 86 · As of 2026-10-14
| Price | 3.00 CNY |
|---|---|
| 1-day change | -4.2% |
| RS rating (overall / 1M / 3M / 12M) | 86 / 90 / 84 / 59 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 29 / 29 / 30 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -4.8% |
| Distance from 52-week high | +24.1% |
| Market cap (USD) | $585.2M |